People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...

Celebrating independence can be important when living with multiple sclerosis, columnist Ben Hofmeister writes.

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

Heat sensitivity makes July 4 columnist Leigh Anne Nelson's least favorite holiday. This year, she'll be listening to her ...

Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...

New advanced imaging technology that detects specific molecules in the brain may find signs of MS lesions months earlier, a ...

Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...

More than 90% of RRMS patients given vidofludimus calcium in a clinical trial were free of confirmed disability worsening ...